Dare Bioscience
DARE
28 hedge funds and large institutions have $2.46M invested in Dare Bioscience in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 6 reducing their positions, and 11 closing their positions.
83% more repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 6
32% more capital inflows, than outflows
Capital inflows: $478K | Capital outflows: $363K
0.21% more ownership
Funds ownership: 6.92% → 7.14% (+0.21%)
22% less funds holding
Funds holding: 36 → 28 (-8)
73% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AMH Equity
Great Neck,
New York
|
+$373K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$39.8K |
| 3 |
Two Sigma Securities
New York
|
+$28.1K |
| 4 |
State Street
Boston,
Massachusetts
|
+$13.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$6.97K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$79.1K |
| 2 |
BlackRock
New York
|
-$77.7K |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$62K |
| 4 |
Founders Financial Securities
Towson,
Maryland
|
-$60.8K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$37.2K |
DARE Hedge Fund Activity: Q2 2024 in Review
28 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q2 2024, worth a combined $2.46M — down 27% from $3.35M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DARE and 3 opened new positions — a net loss of 8 holders — while 6 trimmed existing stakes and 11 added.
The largest buyer was AMH Equity, opening a new position worth an estimated $373K. The largest seller was Citadel Advisors, exiting entirely with an estimated $79.1K sold.
- 28 institutional investors held Dare Bioscience (DARE) as of Q2 2024, down from 36 in Q1 2024.
- Funds reported $2.46M of Dare Bioscience stock for Q2 2024, down 27% quarter-over-quarter.
- 3 funds opened new Dare Bioscience positions in Q2 2024 and 11 closed out, a net change of -8 holders.
- The largest Dare Bioscience buyer in Q2 2024 was AMH Equity, an estimated $373K added.
- The largest Dare Bioscience seller in Q2 2024 was Citadel Advisors, an estimated $79.1K sold.
Based on aggregated 13F filings for Q2 2024.